Lacutamab TELLOMAK-3 confirmatory Phase 3 trial in cutaneous T-cell lymphoma (CTCL) is planned for initiation in H2 2026, ...
TURKU, FI / ACCESS Newswire / March 26, 2026 / Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON), a clinical-stage ...
Today Symphony Space, a U.S.-based aerospace pioneer, announced its official debut and the launch of the Adagio Platform, the ...
Thermo Fisher Scientific and SHL Medical have formed a strategic collaboration to deliver integrated drug device solutions, ...
The Teleradiology Market has emerged as a vital component of modern healthcare systems as medical institutions increasingly ...
Application submitted for manufacturing and marketing approval of ripretinib in Japan for the indication of “gastrointestinal stromal tumor that has progressed following cancer chemotherapy”Ripretinib ...
STOCKHOLM, SE / ACCESS Newswire / March 26, 2026 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today ...
Backed by strong diagnostics market growth and industry consolidation, the transaction positions Axonia Medical to expand ...
Meta ordered to pay $2.1 million, YouTube $900,000; combined with earlier $3 million compensatory award, total damages reach ...
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ...
Newly published findings further support clinical validation of Seaport’s proprietary Glyph™ platform to enable oral dosingData supported advancement of ongoing Phase 2b clinical trial of GlyphAllo in ...
Jurors determine that social media platforms were a "substantial factor” in the plaintiff's depression and suicidal thoughtsLOS ANGELES--(BUSINESS WIRE)--A Los Angeles County Superior Court jury has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results